Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
21.10.2020 13:00:00

Healthcare Services Group, Inc. Reports Q3 2020 Results

Healthcare Services Group, Inc. (NASDAQ:HCSG) (the "Company”) reported for the three months ended September 30, 2020 revenue of $435.9 million, net income of $27.6 million, or $0.37 per basic and diluted common share, and cash flow from operations of $49.2 million. Additionally, the Company’s Board of Directors declared a quarterly cash dividend of $0.205 per common share, the 69th consecutive increase since the initiation of dividend payments in 2003.

Ted Wahl, Chief Executive Officer, stated, "During the quarter, our customers and their caregivers continued to meet the challenges of the pandemic with innovation, resolve and compassion. Our HCSG heroes have been right there with them on the frontlines since the beginning, tirelessly supporting our customers and helping to ensure the well-being of America’s most vulnerable. The health and safety of our employees and the communities we serve will remain our highest priority.”

Mr. Wahl continued, "Our strong financial results underscore our ability to thrive in even the most challenging environments. We were particularly pleased with our service execution during the quarter, as our relentless focus on customer satisfaction, systems adherence and regulatory compliance delivered extraordinary operational outcomes.”

Third Quarter Results

Revenue for the quarter was $435.9 million, with housekeeping & laundry and dining & nutrition segment revenues of $223.4 million and $212.5 million, respectively. Revenue included $9.1 million of COVID-19 supplemental billings, primarily related to employee pay premiums passed through to customers.

Direct cost of services was reported at $365.4 million, or 83.8%. Overall, the Company’s near-term goal remains to manage direct cost at or below 86.0%.

Housekeeping & laundry and dining & nutrition segment margins were 11.1% and 9.2%, respectively.

Selling, general and administrative ("SG&A”) was reported at $37.3 million, or 8.6%; after adjusting for the $3.2 million increase in deferred compensation, actual SG&A was $34.1 million, or 7.8%. The Company continues to target SG&A of 7.5%.

The Company reported an effective tax rate of 25.6% and expects a 2020 tax rate of 24% to 26%.

Cash flow from operations for the quarter was $49.2 million. This includes an $18.7 million decrease in accrued payroll offset by a $17.0 million increase in deferred payroll taxes under the CARES Act.

Mr. Wahl continued, "While the pandemic continues to create uncertainty around near-term occupancy and costs trends, the industry is much better prepared with enhanced operating protocols. Additionally, we continue to be encouraged by the government’s ongoing financial support of the industry, which we view as a necessary bridge from the short-term challenges to a more stable operating environment and, ultimately, a vaccine.”

Mr. Wahl concluded, "As the industry continues to adjust to the new normal, we maintain our sharp focus on delivering strong operational and financial results in Q4. While the current environment necessitates a cautious view on growth, longer term, our growth outlook remains positive as our value proposition is more compelling than ever before. Above all, we remain committed to making decisions that best position us to deliver shareholder value.”

Dividend

The Company’s Board of Directors declared a quarterly cash dividend of $0.205 per common share, payable on December 24, 2020 to shareholders of record at the close of business on November 20, 2020. This represents the 70th consecutive quarterly cash dividend payment, as well as the 69th consecutive increase since the initiation of quarterly cash dividend payments in 2003.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, October 21, 2020, at 8:30 a.m. Eastern Time to discuss its results for the three months ended September 30, 2020. The call may be accessed via phone at 877-395-7164. The call will be simultaneously webcast under the "Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on our website for one year following the date of the earnings call.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes,” "anticipates,” "plans,” "expects,” "will,” "goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services exclusively to the healthcare industry, primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics having a significant portion of our consolidated revenues contributed by one customer during the nine months ended September 30, 2020; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; continued realization of tax benefits arising from our corporate reorganization and self-funded health insurance program; the impact of the Securities and Exchange Commission investigation and related class action lawsuit; risks associated with the reorganization of our corporate structure; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2019 under "Government Regulation of Clients,” "Service Agreements and Collections,” and "Competition” and under Item 1A. "Risk Factors” in such Form 10-K, and in Item 1A. "Risk Factors" of our Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020.

These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected if unexpected increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of professional housekeeping, laundry and dietary services to long-term care and related health care facilities.

HEALTHCARE SERVICES GROUP, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(in thousands, except per share data)

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

September 30,

 

September 30,

 

2020

 

2019

 

2020

 

2019

Revenues

$

435,947

 

 

$

455,606

 

 

$

1,337,126

 

 

$

1,393,818

 

Operating costs and expenses:

 

 

 

 

 

 

 

Cost of services provided

 

365,443

 

 

 

398,404

 

 

 

1,140,116

 

 

 

1,226,154

 

Selling, general and administrative

 

37,337

 

 

 

33,479

 

 

 

108,819

 

 

 

113,189

 

Income from operations

 

33,167

 

 

 

23,723

 

 

 

88,191

 

 

 

54,475

 

Other income, net:

 

 

 

 

 

 

 

Investment and other income, net

 

3,965

 

 

(7

)

 

 

6,135

 

 

4,750

Income before income taxes

 

37,132

 

 

 

23,716

 

 

 

94,326

 

 

 

59,225

 

Income tax expense

 

9,488

 

 

 

5,372

 

 

 

23,391

 

 

 

13,539

 

 

 

 

 

 

 

 

 

Net income

$

27,644

 

 

$

18,344

 

 

$

70,935

 

 

$

45,686

 

 

 

 

 

 

 

 

 

Basic earnings per common share

$

0.37

 

 

$

0.25

 

 

$

0.95

 

 

$

0.61

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

$

0.37

 

 

$

0.25

 

 

$

0.95

 

 

$

0.61

 

 

 

 

 

 

 

 

 

Cash dividends declared per common share

$

0.20500

 

 

$

0.20000

 

 

$

0.61125

 

 

$

0.59625

 

 

 

 

 

 

 

 

 

Basic weighted average number of common shares outstanding

 

74,700

 

 

 

74,387

 

 

 

74,684

 

 

 

74,347

 

 

 

 

 

 

 

 

 

Diluted weighted average number of common shares outstanding

 

74,777

 

 

 

74,507

 

 

 

74,768

 

 

 

74,615

 

HEALTHCARE SERVICES GROUP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(in thousands)

 

 

September 30, 2020

 

December 31, 2019

Cash and cash equivalents

$

109,920

 

 

$

27,329

 

Marketable securities, at fair value

 

94,042

 

 

90,711

Accounts and notes receivable, net

 

277,031

 

 

 

340,930

 

Other current assets

 

56,526

 

 

 

56,762

 

Total current assets

 

537,519

 

 

 

515,732

 

 

 

 

 

Property and equipment, net

 

27,807

 

 

 

28,820

 

Notes receivable - long-term

 

39,458

 

 

 

46,992

 

Goodwill

 

51,084

 

 

 

51,084

 

Other intangible assets, net

 

19,229

 

 

 

22,353

 

Deferred compensation funding

 

40,969

 

 

 

37,247

 

Other assets

 

38,265

 

 

 

20,364

 

Total Assets

$

754,331

 

 

$

722,592

 

 

 

 

 

Accrued insurance claims - current

$

25,776

 

 

$

23,256

 

Other current liabilities

 

108,520

 

 

 

125,395

 

Total current liabilities

 

134,296

 

 

 

148,651

 

 

 

 

 

Accrued insurance claims - long-term

 

70,296

 

 

 

64,366

 

Deferred compensation liability

 

41,045

 

 

 

37,621

 

Other non-current liabilities

 

43,944

 

 

 

11,649

 

 

 

 

 

Stockholders' equity

 

464,750

 

 

 

460,305

 

Total Liabilities and Stockholders' Equity

$

754,331

 

 

$

722,592

 

 

Analysen zu Healthcare Services Group Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Healthcare Services Group Inc. 11,80 0,85% Healthcare Services Group Inc.